ClinicalTrials.Veeva

Menu

Sculptra for Décolletage Crepiness and Wrinkling

S

Skin Laser & Surgery Specialists

Status

Completed

Conditions

Décolletage

Treatments

Other: Sculpta

Study type

Interventional

Funder types

Other

Identifiers

NCT03508973
SCULPTDEC01

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and efficacy of Sculptra as a volume agent to improve décolletage crepiness and wrinkling.

Enrollment

25 patients

Sex

Female

Ages

40 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Female volunteer
  • Aged from 40-70 years on the day of screening
  • No known medical conditions that may interfere with study participation
  • Moderate to severe crepiness and wrinkling of the décolletage
  • Willingness to not use any products on their décolleté for the duration of the study
  • Read, understand, and sign informed consent forms
  • Willingness to sign photography release form
  • Willing and able to comply with all follow-up requirements
  • Willingness to undergo a series of three Sculptra injections, 2-3 months apart, in their décolletage

Exclusion criteria

  • Any significant skin disease at treatment area
  • Any medical condition which could interfere with the treatment
  • Inability or unwillingness to follow the treatment schedule
  • Inability or unwillingness to sign the informed consent
  • History of poor wound healing
  • History of keloid formation
  • History of HIV, hepatitis, immuno-compromised
  • Pregnant or lactating
  • Previous use of deep chemical peels on the treatment area
  • Previous injections of Sculptra in the décolletage
  • Known hypersensitivity to Sculptra or any of its ingredients
  • Previous laser or light based treatments to the treatment area 6 months prior to the screening visit

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

25 participants in 1 patient group

Sculptra
Experimental group
Description:
Sculptra, an injectable implant containing microparticles of ply-L-lactic acid, carboxymethylcellulose, non-pyrogenic mannitol and sterile water, will be injected into the decolletage.
Treatment:
Other: Sculpta

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems